These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22444165)

  • 1. Pneumococcal infections: association with asthma and COPD.
    Obert J; Burgel PR
    Med Mal Infect; 2012 May; 42(5):188-92. PubMed ID: 22444165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal vaccination among adults with chronic respiratory diseases: a historical overview.
    Vila-Corcoles A; Ochoa-Gondar O
    Expert Rev Vaccines; 2012 Feb; 11(2):221-36. PubMed ID: 22309670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of pneumococcal polysaccharide vaccine in older adults.
    Jackson LA; Neuzil KM; Yu O; Benson P; Barlow WE; Adams AL; Hanson CA; Mahoney LD; Shay DK; Thompson WW;
    N Engl J Med; 2003 May; 348(18):1747-55. PubMed ID: 12724480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bacteremic pneumococcal pneumonia].
    Pineda Solas V; Pérez Benito A; Domingo Puiggros M; Larramona Carrera H; Segura Porta F; Fontanals Aymerich D
    An Esp Pediatr; 2002 Nov; 57(5):408-13. PubMed ID: 12467543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seasonality of both bacteremic and nonbacteremic pneumonia coincides with viral lower respiratory tract infections in early childhood, in contrast to nonpneumonia invasive pneumococcal disease, in the pre-pneumococcal conjugate vaccine era.
    Ben-Shimol S; Greenberg D; Hazan G; Shemer-Avni Y; Givon-Lavi N; Dagan R
    Clin Infect Dis; 2015 May; 60(9):1384-7. PubMed ID: 25595749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paediatric asthma and pneumococcal vaccination.
    Esposito S; Musio A; Principi N
    Vaccine; 2013 Oct; 31(44):5015-9. PubMed ID: 24021307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal disease manifestation in children before and after vaccination: what's new?
    Andrade AL; Toscano CM; Minamisava R; Costa PS; Andrade JG
    Vaccine; 2011 Sep; 29 Suppl 3():C2-14. PubMed ID: 21896349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations.
    Adam D; Fehnle K
    Vaccine; 2008 Nov; 26(47):5944-51. PubMed ID: 18801402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines.
    Lynch JP; Zhanel GG
    Curr Opin Pulm Med; 2010 May; 16(3):217-25. PubMed ID: 20375783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based impact of pneumococcal conjugate vaccine in young children.
    Poehling KA; Lafleur BJ; Szilagyi PG; Edwards KM; Mitchel E; Barth R; Schwartz B; Griffin MR
    Pediatrics; 2004 Sep; 114(3):755-61. PubMed ID: 15342850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of pneumococcal conjugate vaccination in Australia.
    Butler JR; McIntyre P; MacIntyre CR; Gilmour R; Howarth AL; Sander B
    Vaccine; 2004 Mar; 22(9-10):1138-49. PubMed ID: 15003641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe.
    Fedson DS; Nicolas-Spony L; Klemets P; van der Linden M; Marques A; Salleras L; Samson SI
    Expert Rev Vaccines; 2011 Aug; 10(8):1143-67. PubMed ID: 21810065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic obstructive pulmonary disease and risk of infection.
    Lange P
    Pneumonol Alergol Pol; 2009; 77(3):284-8. PubMed ID: 19591100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paediatricians' perspectives on the use of pneumococcal vaccine in healthy and asthmatic children.
    Karakaş T; Şahiner UM; Soyer OU; Civelek E; Cokugras H; Şekerel BE
    Allergol Immunopathol (Madr); 2010; 38(5):241-5. PubMed ID: 20656396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiology of pneumococcal infection in children in the developing world.
    Greenwood B
    Philos Trans R Soc Lond B Biol Sci; 1999 Apr; 354(1384):777-85. PubMed ID: 10365403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher pneumococcal disease vaccination rates needed to protect more at-risk US adults.
    Rehm SJ; Farley MM; File TM; Hall WJ; Hopkins R; Levine OS; Nichol KL; Nuorti P; Zimmerman RK; Schaffner W
    Postgrad Med; 2009 Nov; 121(6):101-5. PubMed ID: 19940420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of pneumococcal disease through vaccination.
    Gentile A; Bazán V
    Vaccine; 2011 Sep; 29 Suppl 3():C15-25. PubMed ID: 21896348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.
    Ho PL; Chiu SS; Chow FK; Mak GC; Lau YL
    Vaccine; 2007 Sep; 25(39-40):6837-41. PubMed ID: 17714837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD.
    Schembri S; Morant S; Winter JH; MacDonald TM
    Thorax; 2009 Jul; 64(7):567-72. PubMed ID: 19321465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae.
    O'Brien KL; Nohynek H;
    Pediatr Infect Dis J; 2003 Feb; 22(2):e1-11. PubMed ID: 12586987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.